evans blue has been researched along with Oral Ulcer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, APNN; Avelar, RL; de Aguiar, MT; de Barros Silva, PG; Dias, CC; Fonseca, APR; Freitas, MO; Sousa, FB | 1 |
1 other study(ies) available for evans blue and Oral Ulcer
| Article | Year |
|---|---|
Tumor necrosis factor alpha (TNF-α) blockage reduces acute inflammation and delayed wound healing in oral ulcer of rats.
Topics: Actins; Animals; Collagen; Cytokines; Evans Blue; Inflammation; Infliximab; Interleukin-8; Male; Oral Ulcer; Rats; Rats, Wistar; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Ulcer; Wound Healing | 2022 |